Reproductive technology startup Orchid on Tuesday announced a comprehensive new genetic test that may help many prospective parents across the U.S. breathe a little easier. Stream Connecticut News for ...

Add Yahoo as a preferred source to see more of our stories on Google. For decades, scientists have theorized that two genetic defects have the potential to essentially “cancel each other out,” ...

Sucrase-isomaltase (SI) is an intestinal enzyme critical for the digestion of dietary carbohydrates, particularly sucrose and starch. Previous studies from the Gastrointestinal Genetics team at CIC ...

It impacts roughly 1 in 300 Americans — and puts people at a higher risk of developing cancer before age 50.

Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only minor ...

The MarketWatch News Department was not involved in the creation of this content.-- New research advances genetic diagnosis -- Demonstrates the potential to expand equitable acces ...

Scientists in China have developed a "capsule" delivery system to transplant healthy mitochondria into diseased cells, a ...

As the consumption and legalization of marijuana have increased in the United States, more experts are researching the potential harm from its use, specifically its impact on fertility. A new study ...

Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring ...

Several children in the UAE, facing developmental delays and muscle weakness underwent standard genetic tests only for the ...

Reproductive technology startup Orchid is launching the first commercially available whole genome sequencing test for embryos. The test can identify a child's birth defects, neurodevelopmental ...